Stock Trading History of Renfro Phillip M
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Renfro Phillip M since year 2005.
The trader's CIK number is
1313575.
At the time of this reporting, Renfro Phillip M is the Director of Enzon Pharmaceuticals Inc .
(stock ticker symbol
ENZN).
See this page for
all insider trading activities at Enzon Pharmaceuticals Inc .
Note that in the past
Renfro Phillip M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Renfro Phillip M since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-14 | ENZN | Enzon Pharmaceuticals Inc | Purchase | 10,000 | 3.64 | 36,407 |
| 2008-07-01 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 1,255 | .00 | 0 |
| 2008-07-02 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 3,172 | .00 | 0 |
| 2008-07-03 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 1,105 | .00 | 0 |
| 2008-05-12 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 15,000 | 7.40 | 111,000 |
| 2008-05-12 | ENZN | Enzon Pharmaceuticals Inc | Sale | 15,000 | 9.49 | 142,281 |
| 2008-05-09 | ENZN | Enzon Pharmaceuticals Inc | Sale | 5,487 | 9.46 | 51,907 |
| 2008-04-04 | GSB | Globalscape Inc | Purchase | 10,000 | 2.06 | 20,650 |
| 2008-04-04 | GSB | Globalscape Inc | Purchase | 10,000 | 2.06 | 20,650 |
| 2008-04-04 | GSB | Globalscape Inc | Purchase | 10,000 | 2.06 | 20,650 |
| 2007-07-01 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 1,255 | .00 | 0 |
| 2007-07-03 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 1,105 | .00 | 0 |
| 2006-07-01 | ENZN | Enzon Pharmaceuticals Inc | Option Exercise | 1,255 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Renfro Phillip M
(Director of Enzon Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
